Trials / Completed
CompletedNCT01183221
The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Alexander Kolevzon · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the effects of a single dose of intranasal oxytocin (vs. placebo) on complex social cognition in adults with autism spectrum disorders.
Detailed description
Participants receive a one-time administration of 24-IU intranasal oxytocin (or placebo) and perform an empathic accuracy task, a novel and ecologically valid measure of complex social cognition, in conjunction with functional magnetic resonance imaging (fMRI). The investigators will investigate the effects of oxytocin (versus placebo) on the behavioral and neural correlates of empathic accuracy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Syntocinon | One dose of 24 IU (3 sprays/nostril) |
| DRUG | Placebo | Intranasal Placebo |
Timeline
- Start date
- 2010-06-18
- Primary completion
- 2014-04-25
- Completion
- 2014-04-25
- First posted
- 2010-08-17
- Last updated
- 2021-04-15
- Results posted
- 2021-04-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01183221. Inclusion in this directory is not an endorsement.